MetaCap

Grace Therapeutics (GRCE) vs MindWalk (HYFT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Grace Therapeutics (GRCE) has outperformed MindWalk (HYFT) over the past year, losing 46.4% versus a loss of 59.0%. Over five years, GRCE leads with a -79.3% price change compared with -89.3% for HYFT. Grace Therapeutics is the larger company by market cap ($36.0 million vs $32.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GRCE-46.39%HYFT-59.02%
+73%+4%-65%
Nov 21, 20251 yearNov 20, 2026
GRCE-80.48%HYFT-87.65%
+21%-39%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GRCE versus HYFT key metrics
MetricGRCEHYFT
Share price$1.71$0.6844
Market cap$35.97M$32.56M
1-day change-0.58%-14.27%
YTD return-50.58%-62.40%
1-year return-46.39%-59.02%
5-year return-79.35%-89.34%
EPS (TTM)$-1.16$-0.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-7.79M—
52-week high$5.18$2.99
52-week low$1.64$0.64
Distance from 52-week high-66.99%-77.11%
Analyst consensusnonenone
Avg. price target upside+243.27%+532.67%
Average volume119.27K257.86K
Shares outstanding21.04M47.57M
Employees574
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GRCE has outperformed HYFT by 12.6 percentage points over the past year.

About Grace Therapeutics

GRCE stock →

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About MindWalk

HYFT stock →

MindWalk Holdings Corp. operates as a bio-native AI company.

Health Care · Biotechnology: Pharmaceutical Preparations · 74 employees

GRCE vs HYFT FAQ

Which is bigger, Grace Therapeutics or MindWalk?

Grace Therapeutics (GRCE) is larger, with a market capitalization of $35.97M compared with $32.56M for MindWalk (HYFT).

Which stock has performed better over the past year, GRCE or HYFT?

GRCE returned -46.39% over the past 12 months, compared with -59.02% for HYFT (price return, excluding dividends). Past performance does not predict future results.

Are Grace Therapeutics and MindWalk in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons